ALPROSTADIL Side Effects

6980682-0 | International Normalised Ratio Increased, Prothrombin Time Prolonged
on Aug 25, 2010 Male patient from GERMANY , 80 years of age, was diagnosed with diabetic vascular disorder and was treated with Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased, prothrombin time prolonged. Alprostadil dosage: 20 Mcg, 40 Mcg.

6893006-4 | Prostatitis, Rash
Patient was taking Alprostadil (View Usage). Patient had the following side effects: prostatitis, rash (What is rash?) on Jan 10, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 180.0 lb, . Alprostadil dosage: 40 Ug, As Needed. During the same period patient was treated with LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), ATENOLOL (Unk) (View Atenolol Review and Atenolol Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ).

6817333-1 | Arteriosclerosis Obliterans, Bursitis, Cardiac Failure, Diabetes Mellitus, Necrosis, Pain, Peripheral Ischaemia, Pneumonia
Adverse event was reported on Jun 21, 2010 by a Female patient taking Alprostadil (View Usage) (Dosage: 40 Ug Bid Intravenous (not Otherwise Specified)) was diagnosed with peripheral ischaemia and. Location: RUSSIAN FEDERATION , weighting 163.1 lb, After Alprostadil was administered, patient had the following side effects: arteriosclerosis obliterans, bursitis (What is bursitis?), cardiac failure, diabetes mellitus, necrosis, pain (What is pain?), peripheral ischaemia, pneumonia (What is pneumonia?). During the same period patient was treated with PROMEDOL (View Promedol Review and Promedol Label ), DIPYRONE INJ (View Dipyrone Inj Review and Dipyrone Inj Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), ACTOVEGIN (View Actovegin Review and Actovegin Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), INSULILN PROTAPHAN HUMAN (View Insuliln Protaphan Human Review and Insuliln Protaphan Human Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), PROTAPHANE (View Protaphane Review and Protaphane Label ).

6775253-5 | Apnoeic Attack, Feeling Jittery, Hyperthermia, Incorrect Dose Administered
on Jun 15, 2010 Male patient from UNITED STATES , weighting 6.61 lb, was diagnosed with heart disease congenital and was treated with Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: apnoeic attack, feeling jittery, hyperthermia, incorrect dose administered. Alprostadil dosage: 0.2mcg/kg/min.


6750501-6 | Bursitis, Cardiac Failure, Cellulitis, Condition Aggravated, Diabetes Mellitus, Disease Progression, Leg Amputation, Lobar Pneumonia, Peripheral Ischaemia
on May 18, 2010 Female patient from RUSSIAN FEDERATION , weighting 163.1 lb, was diagnosed with peripheral ischaemia and was treated with Alprostadil (View Usage). Patient had the following side effects: bursitis (What is bursitis?), cardiac failure, cellulitis (What is cellulitis?), condition aggravated, diabetes mellitus, disease progression, leg amputation, lobar pneumonia, peripheral ischaemia. Alprostadil dosage: (90 ?g Bid Intravenous (not Otherwise Specified)). During the same period patient was treated with PROMEDOL (View Promedol Review and Promedol Label ), ANALGIN /00039501/ (View Analgin /00039501/ Review and Analgin /00039501/ Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), ACTOVEGIN (View Actovegin Review and Actovegin Label ), ACTRAPID /00646001/ (View Actrapid /00646001/ Review and Actrapid /00646001/ Label ), INSULIN PROTAPHAN HUMAN (View Insulin Protaphan Human Review and Insulin Protaphan Human Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ).

6739135-7 | Bursitis, Cellulitis, Ischaemia
Patient was taking Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: bursitis (What is bursitis?), cellulitis (What is cellulitis?), ischaemia on May 12, 2010 from RUSSIAN FEDERATION Additional patient health information: Female patient , weighting 163.1 lb, was diagnosed with peripheral ischaemia and. Alprostadil dosage: (40 Ug Bid Intravenous (not Otherwise Specified). During the same period patient was treated with PROMEDOL (View Promedol Review and Promedol Label ), ANALGIN /00039501/ (View Analgin /00039501/ Review and Analgin /00039501/ Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), ACTOVEGIN (View Actovegin Review and Actovegin Label ), ACTRAPID /00646001/ (View Actrapid /00646001/ Review and Actrapid /00646001/ Label ), INSULIN, PROTAPHAN HUMAN (View Insulin, Protaphan Human Review and Insulin, Protaphan Human Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ).

6720887-7 | Bursitis, Cardiac Failure, Cellulitis, Condition Aggravated, Diabetes Mellitus, Disease Progression, Leg Amputation, Lobar Pneumonia, Peripheral Ischaemia
Adverse event was reported on May 03, 2010 by a Female patient taking Alprostadil (View Usage) (Dosage: 40 Ug Bid Intravenous (not Otherwise Specified)) was diagnosed with peripheral ischaemia and. Location: RUSSIAN FEDERATION , weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: bursitis (What is bursitis?), cardiac failure, cellulitis (What is cellulitis?), condition aggravated, diabetes mellitus, disease progression, leg amputation, lobar pneumonia, peripheral ischaemia. During the same period patient was treated with PROMEDOL (View Promedol Review and Promedol Label ), DIPYRONE INJ (View Dipyrone Inj Review and Dipyrone Inj Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), ACTOVEGIN (View Actovegin Review and Actovegin Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), INSULIN PROTAPHAN HUMAN (View Insulin Protaphan Human Review and Insulin Protaphan Human Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ).

6679172-4 | Bursitis, Cardiac Failure, Lobar Pneumonia
on Mar 29, 2010 Female patient from RUSSIAN FEDERATION , weighting 163.1 lb, was diagnosed with peripheral ischaemia and was treated with Alprostadil (View Usage). Patient had the following side effects: bursitis (What is bursitis?), cardiac failure, lobar pneumonia. Alprostadil dosage: (40 Ug Bid Intravenous (not Otherwise Specified)). During the same period patient was treated with PROMEDOL (View Promedol Review and Promedol Label ), ANALGIN /00039501/ (View Analgin /00039501/ Review and Analgin /00039501/ Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), ACTOVEGIN (View Actovegin Review and Actovegin Label ), ACTRAPID /00646001/ (View Actrapid /00646001/ Review and Actrapid /00646001/ Label ), INSULIN PROTAPHAN HUMAN (View Insulin Protaphan Human Review and Insulin Protaphan Human Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ).

6660738-2 | Infection
on Mar 18, 2010 Female patient from JAPAN , 80 years of age, was diagnosed with intestinal ischaemia and was treated with Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: infection (What is infection?). Alprostadil dosage: (0.03 Ug/kg 1x/minute Intravenous (not Otherwise Specified)). Patient was hospitalized.

6660737-0 | Disease Progression, Gastrointestinal Necrosis, Intestinal Ischaemia, Sepsis
Patient was taking Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, gastrointestinal necrosis, intestinal ischaemia, sepsis (What is sepsis?) on Mar 18, 2010 from JAPAN Additional patient health information: Female patient , 83 years of age, was diagnosed with intestinal ischaemia and. Alprostadil dosage: (0.03 Ug/kg 1x/minute Intravenous (not Otherwise Specified)). Patient was hospitalized.

6644609-3 | Arterial Occlusive Disease, Arterial Thrombosis, Finger Amputation, Gangrene, Haemoglobin Decreased, Respiratory Rate Increased, Streptococcus Test Positive, Vasculitis Necrotising
Adverse event was reported on Mar 03, 2010 by a Female patient taking Alprostadil (View Usage) (Dosage: ) . Location: KOREA, REPUBLIC OF , 34 years of age, Patient had the following side effects: arterial occlusive disease, arterial thrombosis, finger amputation, gangrene, haemoglobin decreased, respiratory rate increased, streptococcus test positive, vasculitis necrotising. During the same period patient was treated with PREDNISOLONE ((60 Mg Qd)) (View Prednisolone Review and Prednisolone Label ).

6641439-3 | Bradycardia, Dizziness, Presyncope
on Mar 17, 2010 Male patient from UNITED STATES , 77 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and was treated with Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: bradycardia, dizziness (What is dizziness?), presyncope. Alprostadil dosage: 1000 Mcg Once Other. Patient was hospitalized.

6638808-4 | Bursitis
on Feb 25, 2010 Female patient from RUSSIAN FEDERATION , weighting 163.1 lb, was diagnosed with peripheral ischaemia and was treated with Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: bursitis (What is bursitis?). Alprostadil dosage: 40 Ug Bid Intravenous (not Otherwise Specified). During the same period patient was treated with PROMEDOL (View Promedol Review and Promedol Label ), DIPYRONE INJ (View Dipyrone Inj Review and Dipyrone Inj Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), ACTOVEGIN (View Actovegin Review and Actovegin Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), INSULIN PROTAPHAN HUMAN (View Insulin Protaphan Human Review and Insulin Protaphan Human Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ).

6637460-1 | Hypoxia, Pulmonary Oedema, Weight Increased
Patient was taking Alprostadil (View Usage). Patient had the following side effects: hypoxia, pulmonary oedema, weight increased on Feb 25, 2010 from JAPAN Additional patient health information: Male patient , 63 years of age, was diagnosed with arterial occlusive disease and. Alprostadil dosage: (60 Ug Bid Intravenous Drip).

6616979-3 | Bursitis, Cellulitis, Joint Effusion, Pain
Adverse event was reported on Feb 18, 2010 by a Female patient taking Alprostadil (View Usage) (Dosage: (40 Ug Bid Intravenous (not Otherwise Specified))) was diagnosed with peripheral ischaemia and. Location: RUSSIAN FEDERATION , weighting 163.1 lb, After Alprostadil was administered, patient had the following side effects: bursitis (What is bursitis?), cellulitis (What is cellulitis?), joint effusion, pain (What is pain?). During the same period patient was treated with PROMEDOL (View Promedol Review and Promedol Label ), ANALGIN /00039501/ (View Analgin /00039501/ Review and Analgin /00039501/ Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), ACTOVEGIN (View Actovegin Review and Actovegin Label ), ACTRAPID /0064601/ (View Actrapid /0064601/ Review and Actrapid /0064601/ Label ), INSULIN PROTAPHAN HUMAN (View Insulin Protaphan Human Review and Insulin Protaphan Human Label ).

6610848-0 | Dialysis, Pulmonary Oedema
on Feb 09, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with arterial occlusive disease and was treated with Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), pulmonary oedema. Alprostadil dosage: 120 Ug Intravenous Drip.

6457829-8 | Transient Global Amnesia
on Nov 05, 2009 Male patient from FRANCE , 58 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and was treated with Alprostadil (View Usage). Patient had the following side effects: transient global amnesia. Alprostadil dosage: 20 Mg 2x/week Intracavernous.

6358965-7 | Erection Increased, Incorrect Dose Administered, Overdose
Patient was taking Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: erection increased, incorrect dose administered, overdose on Jul 30, 2009 from GERMANY Additional patient health information: Male patient , 55 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and. Alprostadil dosage: Single Dose: 2.5. Patient was hospitalized.

6358939-6 | Rhabdomyolysis
Adverse event was reported on Aug 27, 2009 by a Male patient taking Alprostadil (View Usage) (Dosage: (intravenous (not Otherwise Specified))) was diagnosed with peripheral arterial occlusive disease and. Location: GERMANY , 71 years of age, Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Patient was hospitalized.

6308608-3 | Priapism
on Jun 24, 2008 Male patient from UNITED STATES , weighting 180.3 lb, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and was treated with Alprostadil (View Usage). Patient had the following side effects: priapism. Alprostadil dosage: See Image.

6295409-8 | Acute Coronary Syndrome, Aortic Stenosis, Aortic Valve Disease, Aortic Valve Incompetence, Arteriosclerosis, Atrial Fibrillation, Atrioventricular Block, Bacterial Infection, Bundle Branch Block Right
on Apr 28, 2004 Male patient from GERMANY , weighting 185.2 lb, was diagnosed with intermittent claudication and was treated with Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: acute coronary syndrome, aortic stenosis, aortic valve disease, aortic valve incompetence, arteriosclerosis, atrial fibrillation (What is atrial fibrillation?), atrioventricular block, bacterial infection (What is bacterial infection?), bundle branch block right. Alprostadil dosage: (60 ?g 2x/week, 2 Times 60 ?g Per Week Intravenous Drip). During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMARYL (View Amaryl Review and Amaryl Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), PROPYCIL (View Propycil Review and Propycil Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ). Patient was hospitalized.

6278418-4 | Acute Myocardial Infarction, Arrhythmia, Brain Oedema, Hypertension, Loss Of Consciousness, Myocardial Ischaemia, Pain, Respiratory Arrest, Shock
Patient was taking Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, arrhythmia (What is arrhythmia?), brain oedema, hypertension, loss of consciousness, myocardial ischaemia, pain (What is pain?), respiratory arrest, shock on Jul 09, 2009 from RUSSIAN FEDERATION Additional patient health information: Male patient , weighting 185.2 lb, . Alprostadil dosage: (intravenous). During the same period patient was treated with PENTOXIFYLLINE (View Pentoxifylline Review and Pentoxifylline Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), VITAMIN A+E /00354001/ (View Vitamin A+e /00354001/ Review and Vitamin A+e /00354001/ Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6239741-2 | Acute Myocardial Infarction, Loss Of Consciousness, Respiratory Arrest, Shock, Ventricular Fibrillation
Adverse event was reported on Jun 04, 2009 by a Male patient taking Alprostadil (View Usage) (Dosage: ) . Location: RUSSIAN FEDERATION , weighting 185.2 lb, Patient had the following side effects: acute myocardial infarction, loss of consciousness, respiratory arrest, shock, ventricular fibrillation. During the same period patient was treated with PENTOXIFYLLINE (View Pentoxifylline Review and Pentoxifylline Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), VITAMIN A+E /00354001/ (View Vitamin A+e /00354001/ Review and Vitamin A+e /00354001/ Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6204918-9 | Rhabdomyolysis
on May 12, 2009 Male patient from GERMANY , 71 years of age, was treated with Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: rhabdomyolysis. Alprostadil dosage: . Patient was hospitalized.

6204875-5 | Acute Myocardial Infarction, Electrolyte Imbalance, Heart Rate Increased, Loss Of Consciousness, Muscle Spasms, Pain, Respiratory Arrest, Shock, Ventricular Fibrillation
on May 13, 2009 Male patient from RUSSIAN FEDERATION , weighting 185.2 lb, was treated with Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, electrolyte imbalance, heart rate increased, loss of consciousness, muscle spasms, pain (What is pain?), respiratory arrest, shock, ventricular fibrillation. Alprostadil dosage: . During the same period patient was treated with PENTOXIFYLLINE (View Pentoxifylline Review and Pentoxifylline Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), VITAMIN A+E /00354001/ (View Vitamin A+e /00354001/ Review and Vitamin A+e /00354001/ Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6193566-5 | Cardiac Disorder, Myocardial Infarction
Patient was taking Alprostadil (View Usage). Patient had the following side effects: cardiac disorder, myocardial infarction on Apr 30, 2009 from GERMANY Additional patient health information: Male patient , 75 years of age, was diagnosed with peripheral arterial occlusive disease and. Alprostadil dosage: (1 Vial Once Intra-arterial). During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), HEPARIN ((5000ie Once)) (View Heparin Review and Heparin Label ), ASPIRIN ((100 Mg, 100 Mg Once) ; (100 Mg Qd, 100mg Daily)) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL ((75 Mg , 75mg Once)) (View Clopidogrel Review and Clopidogrel Label ), PLETAL ((100 Mg Bid)) (View Pletal Review and Pletal Label ).

6188101-1 | Acute Myocardial Infarction, Loss Of Consciousness, Respiratory Arrest, Ventricular Fibrillation
Adverse event was reported on Apr 28, 2009 by a Male patient taking Alprostadil (View Usage) (Dosage: ) . Location: RUSSIAN FEDERATION , weighting 185.2 lb, After Alprostadil was administered, patient had the following side effects: acute myocardial infarction, loss of consciousness, respiratory arrest, ventricular fibrillation. During the same period patient was treated with PENTOXIFXLLIN (View Pentoxifxllin Review and Pentoxifxllin Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), VITAMIN A+E /00354001/ (View Vitamin A+e /00354001/ Review and Vitamin A+e /00354001/ Label ).

6183715-7 | Acute Myocardial Infarction, Loss Of Consciousness, Respiratory Arrest, Ventricular Fibrillation
on Apr 22, 2009 Male patient from RUSSIAN FEDERATION , weighting 185.2 lb, was treated with Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, loss of consciousness, respiratory arrest, ventricular fibrillation. Alprostadil dosage: . During the same period patient was treated with PENTOXIFYLLINE (View Pentoxifylline Review and Pentoxifylline Label ), NICOTINIC ACID (View Nicotinic Acid Review and Nicotinic Acid Label ), VITAMIN A+E /00354001/ (View Vitamin A+e /00354001/ Review and Vitamin A+e /00354001/ Label ).

6125345-9 | Arteriospasm Coronary, Atrioventricular Block, Bradycardia, Cardiac Arrest, Electrocardiogram St Segment Depression, Electrocardiogram St Segment Elevation, Electrocardiogram T Wave Inversion, Hypotension, No Therapeutic Response
on Mar 06, 2009 Female patient from JAPAN , 60 years of age, weighting 119.0 lb, was diagnosed with hypotension, induction of anaesthesia and was treated with Alprostadil (View Usage). Patient had the following side effects: arteriospasm coronary, atrioventricular block, bradycardia, cardiac arrest (What is cardiac arrest?), electrocardiogram st segment depression, electrocardiogram st segment elevation, electrocardiogram t wave inversion, hypotension, no therapeutic response. Alprostadil dosage: 0.03 Ug/kg/min, Cont, Infusion. During the same period patient was treated with PROPOFOL (Intravenous) (View Propofol Review and Propofol Label ), PROPRANOLOL (0.6 Mg, Intravenous) (View Propranolol Review and Propranolol Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), NITROUS OXIDE W/ OXYGEN (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ).

6077552-1 | Interstitial Lung Disease
Patient was taking Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: interstitial lung disease on Jan 26, 2009 from JAPAN Additional patient health information: Male patient , 74 years of age, was diagnosed with arteriosclerosis obliterans and. Alprostadil dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with DORNER (View Dorner Review and Dorner Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6062844-2 | Anuria, Cardiac Failure Congestive, Condition Aggravated, Ileus Paralytic, Metabolic Acidosis, Peritoneal Dialysis
Adverse event was reported on Jan 13, 2009 by a Female patient taking Alprostadil (View Usage) (Dosage: ) was diagnosed with ductus arteriosus premature closure and. Location: JAPAN , weighting 4.41 lb, Patient experienced the following unwanted or unexpected effects: anuria, cardiac failure congestive, condition aggravated, ileus paralytic, metabolic acidosis, peritoneal dialysis. During the same period patient was treated with ALPROSTADIL ALFADEX (View Alprostadil Alfadex Review and Alprostadil Alfadex Label ). Patient was hospitalized.

6054960-6 | Condition Aggravated, Extremity Necrosis, Ulcer
on Jan 06, 2009 Female patient from JAPAN , 44 years of age, weighting 136.7 lb, was diagnosed with skin necrosis and was treated with Alprostadil (View Usage). Patient had the following side effects: condition aggravated, extremity necrosis, ulcer (What is ulcer?). Alprostadil dosage: (10 ?g Intravenous)). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

6020469-9 | Bronchopneumonia, Condition Aggravated, Disease Progression, Duodenal Ulcer, Electrolyte Imbalance, Gastric Haemorrhage, Gastric Ulcer Haemorrhage, Leg Amputation, Mucosal Erosion
on Jun 28, 2006 Female patient from POLAND , 77 years of age, was diagnosed with peripheral ischaemia and was treated with Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: bronchopneumonia, condition aggravated, disease progression, duodenal ulcer, electrolyte imbalance, gastric haemorrhage, gastric ulcer haemorrhage, leg amputation, mucosal erosion. Alprostadil dosage: 2 X 40 Mcg Per Day Intravenous Drip. During the same period patient was treated with KETOPROFEN 100MG, AMPOULES (KETOPROFEN) (View Ketoprofen 100mg, Ampoules (ketoprofen) Review and Ketoprofen 100mg, Ampoules (ketoprofen) Label ), PETHIDINE HYDROCHLORIDE 50MG, AMPOULES (PETHIDINE HYDROCHLORIDE) (View Pethidine Hydrochloride 50mg, Ampoules (pethidine Hydrochloride) Review and Pethidine Hydrochloride 50mg, Ampoules (pethidine Hydrochloride) Label ), PETHIDINE HYDROCHLORIDE 100MG, AMPOULES (PETHIDINE HYDROCHLORIDE) (View Pethidine Hydrochloride 100mg, Ampoules (pethidine Hydrochloride) Review and Pethidine Hydrochloride 100mg, Ampoules (pethidine Hydrochloride) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMLODIPINE 5MG, TABLETS (AMLODIPINE) (View Amlodipine 5mg, Tablets (amlodipine) Review and Amlodipine 5mg, Tablets (amlodipine) Label ), TICLOPIDINE 250MG, TABLETS (TICLOPIDINE) (View Ticlopidine 250mg, Tablets (ticlopidine) Review and Ticlopidine 250mg, Tablets (ticlopidine) Label ), POTASSIUM CHLORIDE 750MG, TABLETS (POTASSIUM CHLORIDE) (View Potassium Chloride 750mg, Tablets (potassium Chloride) Review and Potassium Chloride 750mg, Tablets (potassium Chloride) Label ), RANITIDINE HYDROCHLORIDE 150MG, TABLETS (RANITIDINE HYDROCHLORIDE) (View Ranitidine Hydrochloride 150mg, Tablets (ranitidine Hydrochloride) Review and Ranitidine Hydrochloride 150mg, Tablets (ranitidine Hydrochloride) Label ). Patient was hospitalized.

5989632-7 | Renal Failure Acute, Respiratory Failure
Patient was taking Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute, respiratory failure on Nov 21, 2008 from GERMANY Additional patient health information: Male patient , 70 years of age, was diagnosed with peripheral arterial occlusive disease and. Alprostadil dosage: . Patient was hospitalized.

5986418-4 | Blood Pressure Decreased, Cerebral Infarction
Adverse event was reported on Apr 24, 2008 by a Male patient taking Alprostadil (View Usage) (Dosage: 60 Mcg Intravenous Drip) was diagnosed with peripheral revascularisation and. Location: JAPAN , 69 years of age, Patient had the following side effects: blood pressure decreased, cerebral infarction. During the same period patient was treated with CEFAZOLIN SODIUM HYDRATE (CEFAZOLIN SODIUM) (View Cefazolin Sodium Hydrate (cefazolin Sodium) Review and Cefazolin Sodium Hydrate (cefazolin Sodium) Label ).

5901769-7 | Cardiac Failure, Oedema Peripheral, Pleural Effusion
on Jul 15, 2008 Female patient from GERMANY , 86 years of age, was diagnosed with arterial occlusive disease and was treated with Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: cardiac failure, oedema peripheral, pleural effusion. Alprostadil dosage: 3 Df (1 Df 3 In 1 Day(s) ), Intravenous (not Otherwise Specified).

5876026-8 | Pneumonia
on Aug 21, 2008 Male patient from JAPAN , 74 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Alprostadil dosage: Intravenous. Patient was hospitalized.

5859321-8 | Cardiac Failure, Dyspnoea, Oedema
Patient was taking Alprostadil (View Usage). Patient had the following side effects: cardiac failure, dyspnoea, oedema on Jul 15, 2008 from GERMANY Additional patient health information: Female patient , 86 years of age, was diagnosed with arterial occlusive disease and. Alprostadil dosage: 3 Df (1 Df 3 In 1 Day(s)) Intravenous Intravenous (not Otherwise Specified). Patient was hospitalized.

5848011-3 |
Adverse event was reported on Jun 02, 2008 by a Male patient taking Alprostadil (View Usage) (Dosage: ) . Location: GERMANY , 75 years of age, .

5839412-8 | Aortic Dissection
on May 19, 2008 Male patient from GERMANY , 90 years of age, was treated with Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: aortic dissection. Alprostadil dosage: .

5839411-6 | Cardiac Failure, Dyspnoea, Oedema
on Jul 15, 2008 Female patient from GERMANY , 86 years of age, was diagnosed with arterial occlusive disease and was treated with Alprostadil (View Usage). Patient had the following side effects: cardiac failure, dyspnoea, oedema. Alprostadil dosage: 3 Df ( 1 Df 3 In 1 Day(s)) Intravenous (not Otherwise Specified).

5822335-8 | Skin Necrosis, Swelling, Vessel Puncture Site Haematoma
Patient was taking Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: skin necrosis, swelling, vessel puncture site haematoma on Dec 25, 2007 from JAPAN Additional patient health information: Male patient , 35 years of age, was diagnosed with skin operation and. Alprostadil dosage: 60 Mcg Intravenous Drip. During the same period patient was treated with HEPARIN (10000 Iu Intravenous Drip) (View Heparin Review and Heparin Label ), UROKINASE (UROKINASE) (240000 Iu Intravenous) (View Urokinase (urokinase) Review and Urokinase (urokinase) Label ), DEXTRAN 40 INJ (50 G Intravenous Drip) (View Dextran 40 Inj Review and Dextran 40 Inj Label ), ARBEKACIN SULFATE (ARBEKACIN) (View Arbekacin Sulfate (arbekacin) Review and Arbekacin Sulfate (arbekacin) Label ).

5818258-0 | Cardiac Failure Congestive, Pneumonia Staphylococcal, Pulmonary Oedema
Adverse event was reported on Jun 05, 2008 by a Female patient taking Alprostadil (View Usage) (Dosage: 80 Mcg Intravenous Drip) was diagnosed with arteriosclerosis obliterans and. Location: JAPAN , 80 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, pneumonia staphylococcal, pulmonary oedema. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), BENZBROMARONE (BENZBROMARONE) (View Benzbromarone (benzbromarone) Review and Benzbromarone (benzbromarone) Label ), SARPOGRELATE HYDROCHLORIDE (SARPOGRELATE HYDROCHLORIDE) (View Sarpogrelate Hydrochloride (sarpogrelate Hydrochloride) Review and Sarpogrelate Hydrochloride (sarpogrelate Hydrochloride) Label ), SENNOSIDE A+B (SENNA LEAF) (View Sennoside A+b (senna Leaf) Review and Sennoside A+b (senna Leaf) Label ), SODIUM PICOFULFATE (SODIUM PICOSULFATE) (View Sodium Picofulfate (sodium Picosulfate) Review and Sodium Picofulfate (sodium Picosulfate) Label ), ASIAN GINSENG, ZANTHOXYLUM FRUIT, GINGER, MALT SUGAR (View Asian Ginseng, Zanthoxylum Fruit, Ginger, Malt Sugar Review and Asian Ginseng, Zanthoxylum Fruit, Ginger, Malt Sugar Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

5811251-3 | Blood Pressure Decreased, Cardiac Index Decreased, Disease Complication, Lymphoma, Mitral Valve Disease, Oxygen Saturation Decreased
on Jun 18, 2008 Female patient from JAPAN , 76 years of age, was diagnosed with procedural hypotension and was treated with Alprostadil (View Usage). Patient had the following side effects: blood pressure decreased, cardiac index decreased, disease complication, lymphoma (What is lymphoma?), mitral valve disease, oxygen saturation decreased. Alprostadil dosage: Intravenous Drip. During the same period patient was treated with NICORANDIL (NICORANDIL) (View Nicorandil (nicorandil) Review and Nicorandil (nicorandil) Label ).

5809569-3 | Blood Pressure Decreased, Cardiac Index Decreased, Oxygen Saturation Decreased
on Jun 18, 2008 Female patient from JAPAN , 76 years of age, was diagnosed with procedural hypotension and was treated with Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: blood pressure decreased, cardiac index decreased, oxygen saturation decreased. Alprostadil dosage: Intravenous Drip. During the same period patient was treated with NICORANDIL (NICORANDIL) (View Nicorandil (nicorandil) Review and Nicorandil (nicorandil) Label ).

5806105-2 | Pain, Priapism
Patient was taking Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: pain (What is pain?), priapism on Jul 09, 2008 from UNITED STATES Additional patient health information: Male patient , 50 years of age, weighting 263.9 lb, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and. Alprostadil dosage: 20 Mcg Prn Sq.

5806089-7 | Priapism, Therapeutic Response Unexpected
Adverse event was reported on Jul 09, 2008 by a Male patient taking Alprostadil (View Usage) (Dosage: 40 Mcg Prn Other) was diagnosed with erectile dysfunction (What is erectile dysfunction?) and. Location: UNITED STATES , 61 years of age, weighting 293.2 lb, Patient had the following side effects: priapism, therapeutic response unexpected.

5801798-8 | Blood Pressure Decreased, Cardiac Index Decreased, Oxygen Saturation Decreased
on Jun 18, 2008 Female patient from JAPAN , 76 years of age, was diagnosed with procedural hypotension and was treated with Alprostadil (View Usage). After Alprostadil was administered, patient had the following side effects: blood pressure decreased, cardiac index decreased, oxygen saturation decreased. Alprostadil dosage: Intravenous Drip. During the same period patient was treated with NICORDANDIL (NICORANDIL) (View Nicordandil (nicorandil) Review and Nicordandil (nicorandil) Label ).

5799295-1 | Cerebrovascular Accident
on Jun 23, 2008 Male patient from ITALY , 69 years of age, was diagnosed with systemic sclerosis and was treated with Alprostadil (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Alprostadil dosage: Text:6 Ng/kg/minute. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ). Patient was hospitalized.

5799252-5 | Myocardial Infarction
Patient was taking Alprostadil (View Usage). Patient had the following side effects: myocardial infarction on Jun 23, 2008 from ITALY Additional patient health information: Female patient , 83 years of age, was diagnosed with systemic sclerosis and. Alprostadil dosage: Text:6 Ng/kg/minute. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ). Patient was hospitalized.